Get a Quote

TENAPANOR HYDROCHLORIDE
CAS NO.: 1234365-97-9
Chemical Formula: C50H68Cl6N8O10S2
Molecular Weight: 1218.0000
DMF&GMP status: Please contact us for more details.
Description:
Tenapanor is a novel, small molecule medication approved in September 2019 for the treatment of constipation-predominant irritable bowel-syndrome (IBS-C). It was first designed and synthesized in 2012. As an inhibitor of the sodium/hydrogen exchanger isoform 3 (NHE3) transporter, it is the first and currently only medication within its class and therefore exists as a novel alternative in the treatment of IBS-C.

**The products protected by patents in this product catalog are used for laboratory analysis, research and development, and cannot be sold to any country or region with patent protection and for commercial purpose. If the resulting patent infringement risks and responsibilities will be borne by the buyer.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
TENAPANOR HYDROCHLORIDETABLET;ORALEQ 50MG BASEIBSRELAARDELYX INC
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
854144812/30/2029DSDP
896937712/30/2029DSDP
900628105/02/2030U-2626
940884012/30/2029U-2626
Exclusive Data
Exclusivity Code Exclusivity Expiration
NCE 09/12/2024